# Arresting Vertical Transmission of Hepatitis B Virus

> **NCT03567382** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 179 (actual)

## Conditions studied

- Hepatitis B
- Vertical Transmission of Infectious Disease

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate
- **BIOLOGICAL:** Monovalent HBV vaccine

## Key facts

- **NCT ID:** NCT03567382
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-24
- **Primary completion:** 2020-03-06
- **Final completion:** 2020-08-15
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2021-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03567382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03567382, "Arresting Vertical Transmission of Hepatitis B Virus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03567382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*